Genetic variant identified as potential predictor for severe ulcerative colitis

The HLA-DRB1*01:03 genetic variant is associated with severe ulcerative colitis, significantly raising the risk of major surgeries and hospitalizations.

Ono’s ADC deal; Leo Pharma to conduct layoffs

Plus, news about Booster Therapeutics, Century Therapeutics and Holobiome: Ono Pharmaceutical’s ADC deal: The Japanese drugmaker will pay up to … Sign up to read

October 11, 2024

Relief Therapeutics Announces Executive Changes – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Personnel 03-Jun-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

June 4, 2024

Single Dose Of Next-Gen Psilocybin Shows Significant Reduction In Depression, 20% No Longer Needing Treatment | Psychedelic Spotlight

On Oct 31, 2023, the alternative medicine community woke up to some unprecedented positive data demonstrating psilocybin’s safety and efficacy in treating depression. Cybin, a

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.